The global C-Reactive Protein Testing Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments -By Assay (Immunoturbidimetric Assay, ELISA, Chemiluminescence Immunoassay, Others), By Detection Range (hs-CRP, Conventional CRP, cCRP), By Disease Area (Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus, Others), By End-User (Clinics, Hospitals, Laboratories, Assisted Living Healthcare Facilities, Home, Others).
The C-Reactive Protein (CRP) testing market is expected to grow steadily in 2025, driven by the increasing demand for biomarkers in the early detection of inflammatory and autoimmune diseases. CRP is a protein produced by the liver in response to inflammation, and its levels are often used as a diagnostic marker for a variety of conditions, including cardiovascular diseases, infections, and rheumatoid arthritis. As the global population ages and the incidence of chronic diseases rises, the need for efficient, cost-effective diagnostic tools such as CRP testing is increasing. The market is supported by advances in immunoassay technologies, including point-of-care testing (POCT) devices that allow for rapid, on-site CRP testing in healthcare settings. Additionally, the rise of personalized medicine and preventive healthcare is contributing to the demand for CRP testing, as it plays a key role in monitoring and managing chronic conditions. North America and Europe are expected to remain the largest markets, owing to established healthcare infrastructures and rising healthcare awareness. However, Asia-Pacific is anticipated to witness the fastest growth due to improvements in healthcare access and increasing investments in diagnostic technologies.
The market report analyses the leading companies in the industry including Abbott, Aidian, Boditech Med Inc, Danaher, F. Hoffmann-La Roche Ltd, Getein Biotech Inc, HORIBA Ltd, Merck KGaAA, Ortho Clinical Diagnostics, Quest Diagnostics, Randox Laboratories Ltd, Siemens Healthineers AG, Thermo Fisher Scientific Inc, Zoetis, and others.
The C-reactive protein (CRP) testing market is experiencing a significant trend towards point-of-care (POC) testing solutions. With the demand for rapid diagnostic results, especially in emergency and remote healthcare settings, POC tests are becoming increasingly popular. These tests offer quick results without the need for centralized laboratories, allowing healthcare providers to make faster clinical decisions. The ability to monitor CRP levels in real-time is crucial for managing conditions like infections, inflammatory diseases, and cardiovascular risks, driving the adoption of POC testing kits that provide accurate and timely results.
The rising prevalence of chronic inflammatory conditions, such as rheumatoid arthritis, cardiovascular diseases, and diabetes, is a key driver in the growth of the CRP testing market. CRP is a sensitive marker of inflammation, and monitoring its levels helps healthcare professionals assess disease activity, predict flare-ups, and evaluate the effectiveness of treatments. As the global burden of chronic diseases continues to rise, the demand for reliable and cost-effective CRP testing solutions is expanding, particularly in developing regions with increasing healthcare access.
A significant opportunity lies in the integration of CRP testing into personalized healthcare. With the shift toward personalized medicine, CRP testing can be used to tailor treatment plans based on an individual’s specific inflammatory responses. By monitoring CRP levels in real-time and correlating them with other biomarkers, clinicians can make more informed decisions about treatment adjustments, particularly for patients with complex, multi-condition profiles. Moreover, incorporating CRP testing into wearable health devices or mobile platforms could revolutionize chronic disease management by enabling continuous monitoring and early intervention.
The Immunoturbidimetric Assay segment is expected to lead the C-reactive protein (CRP) testing market by 2025 due to its widespread use in clinical laboratories for CRP quantification. This assay method provides accurate and reliable results, making it highly favored for detecting inflammation and diagnosing diseases such as cardiovascular conditions, autoimmune disorders, and infections. The ease of use, high sensitivity, and quick results offered by immunoturbidimetric assays are key factors that contribute to their dominance in clinical diagnostics. As healthcare providers increasingly prioritize rapid and precise testing for inflammatory markers, the demand for immunoturbidimetric assays is expected to continue to grow, securing its position as the largest segment in the CRP testing market.
The hs-CRP (high-sensitivity C-reactive protein) segment is poised for the highest growth in the C-reactive protein testing market through 2034, as it plays a pivotal role in the early detection of cardiovascular diseases and inflammatory conditions. hs-CRP testing allows for the detection of low levels of C-reactive protein in the blood, which is a sensitive marker for chronic inflammation, often associated with heart disease, stroke, and other cardiovascular conditions. As the global burden of cardiovascular diseases increases, more healthcare providers are adopting hs-CRP testing for routine screenings, particularly in individuals with risk factors for heart disease. This test not only helps in assessing the risk of heart attacks but also provides valuable insight into inflammation-related conditions. With growing awareness of cardiovascular health and the shift toward preventive care, the hs-CRP segment is expected to see significant expansion throughout the forecast period.
The C-Reactive Protein (CRP) testing market in China is experiencing significant growth due to the increasing burden of chronic diseases, rising healthcare awareness, and expanding healthcare infrastructure. CRP tests are essential for detecting inflammation in the body, making them valuable in diagnosing a range of conditions, from infections to cardiovascular diseases. As China’s healthcare system continues to modernize and evolve, demand for accurate diagnostic tools like CRP testing is growing. Moreover, the increasing prevalence of lifestyle-related diseases such as obesity, diabetes, and cardiovascular diseases is pushing the need for regular monitoring and early detection, further fueling the market. The government’s focus on healthcare reforms and expanding access to diagnostic services also plays a key role in driving the market's expansion.
India’s C-Reactive Protein testing market is growing rapidly due to the country’s increasing incidence of chronic diseases and the rising demand for early diagnostic tools. With the rising prevalence of cardiovascular diseases, diabetes, and other inflammatory conditions, CRP testing has become a vital tool for identifying inflammation and monitoring disease progression. The healthcare sector in India is undergoing a transformation, with the government focusing on expanding healthcare access and improving diagnostic services, particularly in rural and underserved regions. Moreover, the increasing awareness about the importance of regular health checkups and the growing adoption of point-of-care testing devices are contributing to the growth of the CRP testing market in India. Additionally, the rise in medical tourism is also propelling the demand for diagnostic testing services.
The United States remains a key player in the C-Reactive Protein testing market, driven by the country’s advanced healthcare infrastructure, high healthcare expenditure, and increasing demand for precise diagnostic tools. CRP testing plays a crucial role in diagnosing and managing various inflammatory conditions, including infections, autoimmune diseases, and cardiovascular diseases. With the growing prevalence of chronic diseases in the U.S., there is an increasing need for early and accurate diagnostic tests to prevent disease complications. Moreover, the rising focus on preventive healthcare and the adoption of personalized medicine are pushing demand for CRP tests as part of routine screenings. Technological advancements, such as the development of high-sensitivity CRP (hs-CRP) tests, are also contributing to the growth of the market by offering more accurate and reliable results.
Germany’s C-Reactive Protein testing market is experiencing steady growth, driven by the country's focus on advanced healthcare and diagnostic solutions. As one of Europe’s leading healthcare markets, Germany has a strong infrastructure for medical testing, and CRP testing plays an integral role in the early diagnosis of inflammatory and cardiovascular diseases. The country’s aging population, along with the increasing prevalence of chronic diseases such as diabetes and hypertension, is fueling demand for CRP tests. Furthermore, Germany’s strong healthcare policies, including reimbursement for diagnostic tests and a focus on improving public health, contribute to the growth of the CRP testing market. The increasing use of point-of-care testing devices in both clinical and home settings is also enhancing market accessibility and driving demand.
In France, the C-Reactive Protein testing market is expanding due to the country’s commitment to improving healthcare services and diagnostics. The rising prevalence of cardiovascular diseases, cancer, and autoimmune disorders has led to a growing demand for CRP testing as a means of early detection and monitoring. France’s well-established healthcare system and strong research initiatives in medical diagnostics contribute to the adoption of advanced CRP testing technologies. Additionally, with an aging population and the increasing focus on preventive healthcare, CRP tests are becoming an essential part of routine health checkups. The growing adoption of home testing kits and point-of-care testing devices further contributes to market expansion by making CRP testing more accessible to patients.
The C-Reactive Protein testing market in the Middle East is seeing significant growth, particularly in countries like the UAE, Saudi Arabia, and Qatar, due to increasing healthcare investments and a rising prevalence of chronic diseases. The region is experiencing an increase in lifestyle-related diseases, including diabetes, hypertension, and cardiovascular conditions, driving the need for diagnostic tests like CRP to detect inflammation. With growing awareness about the importance of early disease detection and the increasing adoption of advanced healthcare technologies, CRP testing is becoming an integral part of clinical practice in the Middle East. Furthermore, government initiatives to improve healthcare infrastructure and provide better diagnostic services are contributing to the market’s growth. The increasing demand for medical tourism in the region also bolsters the need for high-quality diagnostic testing services.
|
Parameter |
Details |
|
Market Size (2025) |
$5.9 Billion |
|
Market Size (2034) |
$9.2 Billion |
|
Market Growth Rate |
5.1% |
|
Segments |
By Assay (Immunoturbidimetric Assay, ELISA, Chemiluminescence Immunoassay, Others), By Detection Range (hs-CRP, Conventional CRP, cCRP), By Disease Area (Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus, Others), By End-User (Clinics, Hospitals, Laboratories, Assisted Living Healthcare Facilities, Home, Others) |
|
Study Period |
2019- 2024 and 2025-2034 |
|
Units |
Revenue (USD) |
|
Qualitative Analysis |
Porter’s Five Forces, SWOT Profile, Market Share, Scenario Forecasts, Market Ecosystem, Company Ranking, Market Dynamics, Industry Benchmarking |
|
Companies |
Abbott, Aidian, Boditech Med Inc, Danaher, F. Hoffmann-La Roche Ltd, Getein Biotech Inc, HORIBA Ltd, Merck KGaAA, Ortho Clinical Diagnostics, Quest Diagnostics, Randox Laboratories Ltd, Siemens Healthineers AG, Thermo Fisher Scientific Inc, Zoetis |
|
Countries |
US, Canada, Mexico, Germany, France, Spain, Italy, UK, Russia, China, India, Japan, South Korea, Australia, South East Asia, Brazil, Argentina, Middle East, Africa |
By Assay
Immunoturbidimetric Assay
ELISA
-Clinical
-Nonclinical
Chemiluminescence Immunoassay
Others
By Detection Range
hs-CRP
Conventional CRP
cCRP
By Disease Area
Cardiovascular Diseases
Cancer
Rheumatoid Arthritis
Inflammatory Bowel Disease
Endometriosis
Lupus
Others
By End-User
Clinics
Hospitals
Laboratories
Assisted Living Healthcare Facilities
Home
Others
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Abbott
Aidian
Boditech Med Inc
Danaher
F. Hoffmann-La Roche Ltd
Getein Biotech Inc
HORIBA Ltd
Merck KGaAA
Ortho Clinical Diagnostics
Quest Diagnostics
Randox Laboratories Ltd
Siemens Healthineers AG
Thermo Fisher Scientific Inc
Zoetis
*- List Not Exhaustive
About USD Analytics
Table of Contents
List of Charts and Exhibits
List of Tables
1. Executive Summary
What’s New in 2025?
Top 10 Takeaways from the industry
Potential Opportunities for Industry Stakeholders
Strategic Imperatives
Company Market Positioning
Industry Benchmarking Matrix
2. Research Scope and Methodology
Market Definition
- Market Segments
- Companies Profiled
Research Methodology
- Bottom-Up Method
- Top-Down Method
- Data Triangulation
Forecast Methodology
- Data Sources
- USDA Proprietary Databases
- External Sources
- Primary Research and Interviews
Conversion Rates for USD
Abbreviations
3. Strategic Landscape: Key Insights and Implications
Spotlight: Key Strategies opted by Business Leaders
Competitive Landscape
Market Size ($ Million) and Share (%) by Company, 2024
SWOT Analysis
- Key Market Strengths
- Key Market Weaknesses
- Potential Opportunities
- Potential Threats
Porter’s Five Force Analysis
- Summary
- Bargaining Power of Buyers- Impact Analysis
- Bargaining Power of Suppliers- Impact Analysis
- Threat of new entrants- Impact Analysis
- Intensity of Competitive Rivalry- Impact Analysis
Macro-Environmental Analysis
- Economic forecasts by Country, 2010- 2035
- Population forecasts by Country, 2010- 2035
- Inflation Outlook by Country, 2010-2035
- Impact of Russia-Ukraine Conflict, Sluggish China Growth, US Developments
5. Growth Opportunity Analysis
Trends at a Glance
- What are the most noteworthy trends in the market
- Where should leaders pay attention?
- What industries are likely to be affected by the growth?
Market Dynamics
- Charting a path forward
- Growth Drivers
- Growth Barriers
Key Industry Stakeholders
- Suppliers
- Manufacturers and Service Providers
- Distribution Channels
- End-Users and Applications
- Regulators
- Investors, Traders, and R&D Institutes
Regulatory Landscape
6. Market Size Outlook to 2034
Global C-Reactive Protein Testing Market Size Forecast, USD Million, 2018- 2034
- Historic Market Size, 2018- 2024
- Forecast Market Size, 2024- 2034
Scenario Analysis
- Low Growth Scenario: Definition and Outlook to 2034
- Reference Case: Definition and Outlook to 2034
- High Growth Scenario: Definition and Outlook to 2034
Pricing Analysis and Outlook
- C-Reactive Protein Testing Average Price Forecast, 2021- 2034
- Key Factors Shaping the Pricing Patterns
7. Historical C-Reactive Protein Testing Market Size by Segments, 2018- 2024
Key Statistics, 2024
C-Reactive Protein Testing Market Size Outlook by Type, USD Million, 2018- 2024
Growth Comparison (y-o-y) across C-Reactive Protein Testing Types, 2018- 2024
C-Reactive Protein Testing Market Size Outlook by Application, USD Million, 2018- 2024
Growth Comparison (y-o-y) across C-Reactive Protein Testing Applications, 2018- 2024
8. C-Reactive Protein Testing Market Size Outlook by Segments, 2024- 2034
By Assay
Immunoturbidimetric Assay
ELISA
-Clinical
-Nonclinical
Chemiluminescence Immunoassay
Others
By Detection Range
hs-CRP
Conventional CRP
cCRP
By Disease Area
Cardiovascular Diseases
Cancer
Rheumatoid Arthritis
Inflammatory Bowel Disease
Endometriosis
Lupus
Others
By End-User
Clinics
Hospitals
Laboratories
Assisted Living Healthcare Facilities
Home
Others
9. C-Reactive Protein Testing Market Size Outlook by Region
North America
Key Market Dynamics
North America C-Reactive Protein Testing Market Size Outlook by Type, USD Million, 2021-2034
North America C-Reactive Protein Testing Market Size Outlook by Application, USD Million, 2021-2034
North America C-Reactive Protein Testing Market Size Outlook by Sales Channel, USD Million, 2021-2034
North America C-Reactive Protein Testing Market Size Outlook by Country, USD Million, 2021-2034
Europe
Key Market Dynamics
Europe C-Reactive Protein Testing Market Size Outlook by Type, USD Million, 2021-2034
Europe C-Reactive Protein Testing Market Size Outlook by Application, USD Million, 2021-2034
Europe C-Reactive Protein Testing Market Size Outlook by Sales Channel, USD Million, 2021-2034
Europe C-Reactive Protein Testing Market Size Outlook by Country, USD Million, 2021-2034
Asia Pacific
Key Market Dynamics
Asia Pacific C-Reactive Protein Testing Market Size Outlook by Type, USD Million, 2021-2034
Asia Pacific C-Reactive Protein Testing Market Size Outlook by Application, USD Million, 2021-2034
Asia Pacific C-Reactive Protein Testing Market Size Outlook by Sales Channel, USD Million, 2021-2034
Asia Pacific C-Reactive Protein Testing Market Size Outlook by Country, USD Million, 2021-2034
South America
Key Market Dynamics
South America C-Reactive Protein Testing Market Size Outlook by Type, USD Million, 2021-2034
South America C-Reactive Protein Testing Market Size Outlook by Application, USD Million, 2021-2034
South America C-Reactive Protein Testing Market Size Outlook by Sales Channel, USD Million, 2021-2034
South America C-Reactive Protein Testing Market Size Outlook by Country, USD Million, 2021-2034
Middle East and Africa
Key Market Dynamics
Middle East and Africa C-Reactive Protein Testing Market Size Outlook by Type, USD Million, 2021-2034
Middle East and Africa C-Reactive Protein Testing Market Size Outlook by Application, USD Million, 2021-2034
Middle East and Africa C-Reactive Protein Testing Market Size Outlook by Sales Channel, USD Million, 2021-2034
Middle East and Africa C-Reactive Protein Testing Market Size Outlook by Country, USD Million, 2021-2034
10. United States C-Reactive Protein Testing Market Analysis and Outlook, 2021- 2034
Key Statistics
United States C-Reactive Protein Testing Market Size Outlook by Type, 2021- 2034
United States C-Reactive Protein Testing Market Size Outlook by Application, 2021- 2034
United States C-Reactive Protein Testing Market Size Outlook by End-User, 2021- 2034
11. Canada C-Reactive Protein Testing Market Analysis and Outlook, 2021- 2034
Key Statistics
Canada C-Reactive Protein Testing Market Size Outlook by Type, 2021- 2034
Canada C-Reactive Protein Testing Market Size Outlook by Application, 2021- 2034
Canada C-Reactive Protein Testing Market Size Outlook by End-User, 2021- 2034
12. Mexico C-Reactive Protein Testing Market Analysis and Outlook, 2021- 2034
Key Statistics
Mexico C-Reactive Protein Testing Market Size Outlook by Type, 2021- 2034
Mexico C-Reactive Protein Testing Market Size Outlook by Application, 2021- 2034
Mexico C-Reactive Protein Testing Market Size Outlook by End-User, 2021- 2034
13. Germany C-Reactive Protein Testing Market Analysis and Outlook, 2021- 2034
Key Statistics
Germany C-Reactive Protein Testing Market Size Outlook by Type, 2021- 2034
Germany C-Reactive Protein Testing Market Size Outlook by Application, 2021- 2034
Germany C-Reactive Protein Testing Market Size Outlook by End-User, 2021- 2034
14. France C-Reactive Protein Testing Market Analysis and Outlook, 2021- 2034
Key Statistics
France C-Reactive Protein Testing Market Size Outlook by Type, 2021- 2034
France C-Reactive Protein Testing Market Size Outlook by Application, 2021- 2034
France C-Reactive Protein Testing Market Size Outlook by End-User, 2021- 2034
15. United Kingdom C-Reactive Protein Testing Market Analysis and Outlook, 2021- 2034
Key Statistics
United Kingdom C-Reactive Protein Testing Market Size Outlook by Type, 2021- 2034
United Kingdom C-Reactive Protein Testing Market Size Outlook by Application, 2021- 2034
United Kingdom C-Reactive Protein Testing Market Size Outlook by End-User, 2021- 2034
16. Spain C-Reactive Protein Testing Market Analysis and Outlook, 2021- 2034
Key Statistics
Spain C-Reactive Protein Testing Market Size Outlook by Type, 2021- 2034
Spain C-Reactive Protein Testing Market Size Outlook by Application, 2021- 2034
Spain C-Reactive Protein Testing Market Size Outlook by End-User, 2021- 2034
17. Italy C-Reactive Protein Testing Market Analysis and Outlook, 2021- 2034
Key Statistics
Italy C-Reactive Protein Testing Market Size Outlook by Type, 2021- 2034
Italy C-Reactive Protein Testing Market Size Outlook by Application, 2021- 2034
Italy C-Reactive Protein Testing Market Size Outlook by End-User, 2021- 2034
18. Benelux C-Reactive Protein Testing Market Analysis and Outlook, 2021- 2034
Key Statistics
Benelux C-Reactive Protein Testing Market Size Outlook by Type, 2021- 2034
Benelux C-Reactive Protein Testing Market Size Outlook by Application, 2021- 2034
Benelux C-Reactive Protein Testing Market Size Outlook by End-User, 2021- 2034
19. Nordic C-Reactive Protein Testing Market Analysis and Outlook, 2021- 2034
Key Statistics
Nordic C-Reactive Protein Testing Market Size Outlook by Type, 2021- 2034
Nordic C-Reactive Protein Testing Market Size Outlook by Application, 2021- 2034
Nordic C-Reactive Protein Testing Market Size Outlook by End-User, 2021- 2034
20. Rest of Europe C-Reactive Protein Testing Market Analysis and Outlook, 2021- 2034
Key Statistics
Rest of Europe C-Reactive Protein Testing Market Size Outlook by Type, 2021- 2034
Rest of Europe C-Reactive Protein Testing Market Size Outlook by Application, 2021- 2034
Rest of Europe C-Reactive Protein Testing Market Size Outlook by End-User, 2021- 2034
21. China C-Reactive Protein Testing Market Analysis and Outlook, 2021- 2034
Key Statistics
China C-Reactive Protein Testing Market Size Outlook by Type, 2021- 2034
China C-Reactive Protein Testing Market Size Outlook by Application, 2021- 2034
China C-Reactive Protein Testing Market Size Outlook by End-User, 2021- 2034
22. India C-Reactive Protein Testing Market Analysis and Outlook, 2021- 2034
Key Statistics
India C-Reactive Protein Testing Market Size Outlook by Type, 2021- 2034
India C-Reactive Protein Testing Market Size Outlook by Application, 2021- 2034
India C-Reactive Protein Testing Market Size Outlook by End-User, 2021- 2034
23. Japan C-Reactive Protein Testing Market Analysis and Outlook, 2021- 2034
Key Statistics
Japan C-Reactive Protein Testing Market Size Outlook by Type, 2021- 2034
Japan C-Reactive Protein Testing Market Size Outlook by Application, 2021- 2034
Japan C-Reactive Protein Testing Market Size Outlook by End-User, 2021- 2034
24. South Korea C-Reactive Protein Testing Market Analysis and Outlook, 2021- 2034
Key Statistics
South Korea C-Reactive Protein Testing Market Size Outlook by Type, 2021- 2034
South Korea C-Reactive Protein Testing Market Size Outlook by Application, 2021- 2034
South Korea C-Reactive Protein Testing Market Size Outlook by End-User, 2021- 2034
25. Australia C-Reactive Protein Testing Market Analysis and Outlook, 2021- 2034
Key Statistics
Australia C-Reactive Protein Testing Market Size Outlook by Type, 2021- 2034
Australia C-Reactive Protein Testing Market Size Outlook by Application, 2021- 2034
Australia C-Reactive Protein Testing Market Size Outlook by End-User, 2021- 2034
26. South East Asia C-Reactive Protein Testing Market Analysis and Outlook, 2021- 2034
Key Statistics
South East Asia C-Reactive Protein Testing Market Size Outlook by Type, 2021- 2034
South East Asia C-Reactive Protein Testing Market Size Outlook by Application, 2021- 2034
South East Asia C-Reactive Protein Testing Market Size Outlook by End-User, 2021- 2034
27. Rest of Asia Pacific C-Reactive Protein Testing Market Analysis and Outlook, 2021- 2034
Key Statistics
Rest of Asia Pacific C-Reactive Protein Testing Market Size Outlook by Type, 2021- 2034
Rest of Asia Pacific C-Reactive Protein Testing Market Size Outlook by Application, 2021- 2034
Rest of Asia Pacific C-Reactive Protein Testing Market Size Outlook by End-User, 2021- 2034
28. Brazil C-Reactive Protein Testing Market Analysis and Outlook, 2021- 2034
Key Statistics
Brazil C-Reactive Protein Testing Market Size Outlook by Type, 2021- 2034
Brazil C-Reactive Protein Testing Market Size Outlook by Application, 2021- 2034
Brazil C-Reactive Protein Testing Market Size Outlook by End-User, 2021- 2034
29. Argentina C-Reactive Protein Testing Market Analysis and Outlook, 2021- 2034
Key Statistics
Argentina C-Reactive Protein Testing Market Size Outlook by Type, 2021- 2034
Argentina C-Reactive Protein Testing Market Size Outlook by Application, 2021- 2034
Argentina C-Reactive Protein Testing Market Size Outlook by End-User, 2021- 2034
30. Rest of South America C-Reactive Protein Testing Market Analysis and Outlook, 2021- 2034
Key Statistics
Rest of South America C-Reactive Protein Testing Market Size Outlook by Type, 2021- 2034
Rest of South America C-Reactive Protein Testing Market Size Outlook by Application, 2021- 2034
Rest of South America C-Reactive Protein Testing Market Size Outlook by End-User, 2021- 2034
31. United Arab Emirates C-Reactive Protein Testing Market Analysis and Outlook, 2021- 2034
Key Statistics
United Arab Emirates C-Reactive Protein Testing Market Size Outlook by Type, 2021- 2034
United Arab Emirates C-Reactive Protein Testing Market Size Outlook by Application, 2021- 2034
United Arab Emirates C-Reactive Protein Testing Market Size Outlook by End-User, 2021- 2034
32. Saudi Arabia C-Reactive Protein Testing Market Analysis and Outlook, 2021- 2034
Key Statistics
Saudi Arabia C-Reactive Protein Testing Market Size Outlook by Type, 2021- 2034
Saudi Arabia C-Reactive Protein Testing Market Size Outlook by Application, 2021- 2034
Saudi Arabia C-Reactive Protein Testing Market Size Outlook by End-User, 2021- 2034
33. Rest of Middle East C-Reactive Protein Testing Market Analysis and Outlook, 2021- 2034
Key Statistics
Rest of Middle East C-Reactive Protein Testing Market Size Outlook by Type, 2021- 2034
Rest of Middle East C-Reactive Protein Testing Market Size Outlook by Application, 2021- 2034
Rest of Middle East C-Reactive Protein Testing Market Size Outlook by End-User, 2021- 2034
34. South Africa C-Reactive Protein Testing Market Analysis and Outlook, 2021- 2034
Key Statistics
South Africa C-Reactive Protein Testing Market Size Outlook by Type, 2021- 2034
South Africa C-Reactive Protein Testing Market Size Outlook by Application, 2021- 2034
South Africa C-Reactive Protein Testing Market Size Outlook by End-User, 2021- 2034
35. Rest of Africa C-Reactive Protein Testing Market Analysis and Outlook, 2021- 2034
Key Statistics
Rest of Africa C-Reactive Protein Testing Market Size Outlook by Type, 2021- 2034
Rest of Africa C-Reactive Protein Testing Market Size Outlook by Application, 2021- 2034
Rest of Africa C-Reactive Protein Testing Market Size Outlook by End-User, 2021- 2034
36. Key Companies
Market Share Analysis
Abbott
Aidian
Boditech Med Inc
Danaher
F. Hoffmann-La Roche Ltd
Getein Biotech Inc
HORIBA Ltd
Merck KGaAA
Ortho Clinical Diagnostics
Quest Diagnostics
Randox Laboratories Ltd
Siemens Healthineers AG
Thermo Fisher Scientific Inc
Zoetis
Company Benchmarking
Financial Analysis
37. Recent Market Developments
38. Appendix
Looking Ahead
Research Methodology
Legal Disclaimer
By Assay
Immunoturbidimetric Assay
ELISA
-Clinical
-Nonclinical
Chemiluminescence Immunoassay
Others
By Detection Range
hs-CRP
Conventional CRP
cCRP
By Disease Area
Cardiovascular Diseases
Cancer
Rheumatoid Arthritis
Inflammatory Bowel Disease
Endometriosis
Lupus
Others
By End-User
Clinics
Hospitals
Laboratories
Assisted Living Healthcare Facilities
Home
Others
The Global C-Reactive Protein Testing Market Size is estimated at $5.9 Billion in 2025 and is forecast to register an annual growth rate (CAGR) of 5.1% to reach $9.2 Billion by 2034.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Abbott, Aidian, Boditech Med Inc, Danaher, F. Hoffmann-La Roche Ltd, Getein Biotech Inc, HORIBA Ltd, Merck KGaAA, Ortho Clinical Diagnostics, Quest Diagnostics, Randox Laboratories Ltd, Siemens Healthineers AG, Thermo Fisher Scientific Inc, Zoetis
Base Year- 2024; Estimated Year- 2025; Historic Period- 2019-2024; Forecast period- 2025 to 2034; Currency: Revenue (USD); Volume